nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A randomized comparison of the treatment sequence of percutaneous coronary intervention and transcatheter aortic valve implantation: Rationale and design of the TAVI PCI trial
|
Stähli, Barbara E. |
|
|
277 |
C |
p. 104-113 |
artikel |
2 |
Blood and urine metal levels in patients with diabetes and cardiovascular disease
|
Kawada, Tomoyuki |
|
|
277 |
C |
p. 142 |
artikel |
3 |
Comparison of machine learning and conventional statistical modeling for predicting readmission following acute heart failure hospitalization
|
Abdul-Samad, Karem |
|
|
277 |
C |
p. 93-103 |
artikel |
4 |
deliVERy of optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria study: Rationale and design of a randomized clinical trial
|
Salam, Abdul |
|
|
277 |
C |
p. 66-75 |
artikel |
5 |
Editorial Board
|
|
|
|
277 |
C |
p. iii-iv |
artikel |
6 |
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design
|
Verghese, Dhiran |
|
|
277 |
C |
p. 20-26 |
artikel |
7 |
Impact of sex on outcomes associated with polyvascular disease in patients after PCI
|
Vogel, Birgit |
|
|
277 |
C |
p. 39-46 |
artikel |
8 |
Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: A randomized pilot study (CAVAL US-AHF study)
|
Burgos, Lucrecia María |
|
|
277 |
C |
p. 47-57 |
artikel |
9 |
Information for Readers
|
|
|
|
277 |
C |
p. v |
artikel |
10 |
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
|
Jain, Sneha S. |
|
|
277 |
C |
p. 145-158 |
artikel |
11 |
Pathological evaluation of predictors for delayed endothelial coverage after currently available drug-eluting stent implantation in coronary arteries: Impact of lesions with acute and chronic coronary syndromes
|
Aihara, Kazuki |
|
|
277 |
C |
p. 114-124 |
artikel |
12 |
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
|
Wu, Zhi-Ming |
|
|
277 |
C |
p. 58-65 |
artikel |
13 |
RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and design
|
Krychtiuk, Konstantin A. |
|
|
277 |
C |
p. 125-137 |
artikel |
14 |
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
|
Erlinge, David |
|
|
277 |
C |
p. 1-10 |
artikel |
15 |
Response to Tomoyuki Kawada: Blood and urine metal levels in patients with diabetes and cardiovascular disease
|
Navas-Acien, Ana |
|
|
277 |
C |
p. 143-144 |
artikel |
16 |
Sex differences and long-term clinical outcomes after transcatheter aortic valve replacement: A SWEDEHEART study
|
Dismorr, Michael |
|
|
277 |
C |
p. 27-38 |
artikel |
17 |
Table of Contents
|
|
|
|
277 |
C |
p. i-ii |
artikel |
18 |
The impact of mavacamten dosing on wall thickness regression: an insight from longer term follow-up based on genetic profile
|
Alsidawi, Said |
|
|
277 |
C |
p. 138-141 |
artikel |
19 |
The pathophysiology of patent foramen ovale and its related complications
|
Shah, Ashish H. |
|
|
277 |
C |
p. 76-92 |
artikel |
20 |
Use of artificial intelligence‐guided echocardiography to detect cardiac dysfunction and heart valve disease in rural and remote areas: Rationale and design of the AGILE‐echo trial
|
Soh, Cheng Hwee |
|
|
277 |
C |
p. 11-19 |
artikel |